Top

Published in:

01-09-2005 | Laboratory Investigation

Expression of Drug Resistance Proteins Pgp, MRP1, MRP3, MRP5 AND GST-π in Human Glioma

Authors: C. Calatozzolo, M. Gelati, E. Ciusani, F. L. Sciacca, B. Pollo, L. Cajola, C. Marras, A. Silvani, L. Vitellaro-Zuccarello, D. Croci, A. Boiardi, A. Salmaggi

Published in: Journal of Neuro-Oncology | Issue 2/2005

Title: Expression of Drug Resistance Proteins Pgp, MRP1, MRP3, MRP5 AND GST-π in Human Glioma
Authors: C. Calatozzolo
M. Gelati
E. Ciusani
F. L. Sciacca
B. Pollo
L. Cajola
C. Marras
A. Silvani
L. Vitellaro-Zuccarello
D. Croci
A. Boiardi
A. Salmaggi
Publication date: 01-09-2005
Publisher: Kluwer Academic Publishers
Published in: Journal of Neuro-Oncology / Issue 2/2005
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI: https://doi.org/10.1007/s11060-004-6152-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Expression of Drug Resistance Proteins Pgp, MRP1, MRP3, MRP5 AND GST-π in Human Glioma

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 2/2005

Unusual Radiological Presentation of PCNSL

The Effect of Height on Paclitaxel Nerve Damage

Malignant Transformation of Intra-Cranial Epithelial Cysts: Systematic Article Review

Growth Retardation and Bilateral Cataracts Followed by Anaplastic Meningioma 23 Years after High-Dose Cranial and Whole-Body Irradiation for Acute Lymphoblastic Leukemia: Case Report and Review of the Literature

Gefitinib (‘Iressa’, ZD1839) is Active against Brain Metastases in a 77 year Old Patient

Secondary Analysis of Radiation Therapy Oncology Group study (RTOG) 9310: An Intergroup Phase II Combined Modality Treatment of Primary Central Nervous System Lymphoma